Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

SHOCKING: Gland pharma - You Need To See This

Gland Pharma block deal: Fosun Pharma divests 99 lakh shares worth Rs 2,800 crore

Fosun Pharma sold a 6% stake in Gland Pharma for ₹2,800 crore via a block deal, reducing its holding to 45.77%. Major buyers included Kotak, Axis, and ICICI Prudential Mutual Funds, while Gland Pharma shares closed higher at ₹2,932.40.

The Economic Times

Large trade alert! Gland Pharma shares fall 3% after 1.2 crore shares change hands in 2 block deals; promoter Fosun likely seller

Gland Pharma shares fell 3% after 1.22 crore shares changed hands in two block deals worth nearly Rs 5,818 crore. Promoter Fosun Pharma Industrial was reportedly looking to sell a 5% stake for Rs 2,279.5 crore. Meanwhile, the company’s recent USFDA inspection of two Visakhapatnam facilities concluded with zero Form…

The Economic Times

Block deal alert! Gland Pharma shares fall 3% as 1.2 crore shares change hands in 2 block deals; promoter Fosun likely seller

Gland Pharma shares fell after a significant block deal involving Fosun Pharma Industrial. The company's VSEZ facility received zero USFDA observations after a recent inspection. Gland Pharma reported strong Q1FY27 results with increased profit and revenue. Its CDMO and B2B businesses showed substantial year-on-year growth. The pharma stock has gained…

The Economic Times

From analysis to the latest developments in health,
read the most diverse news in one place.

Stocks in news: HDFC Bank, M&M, Gland Pharma, CreditAccess Grameen and Bharat Forge

Indian benchmark indices extended their losing streak for a fourth consecutive session on Thursday. Nifty 50 fell 0.17% and Sensex declined 0.55% amid market pressures. HDFC Bank raised nearly $12 billion through Foreign Currency Non-Resident deposits. Mahindra & Mahindra expects truck business integration by January and electric bus launch by…

The Economic Times

Gland Pharma shares: Promoter Fosun Pharma likely to divest 5% equity worth Rs 2,279 crore via block deal

Fosun Pharma plans to divest 5% equity in Gland Pharma through a Rs 2,279.5 crore block deal at Rs 2,763 per share. Gland Pharma reported a 47% rise in Q1FY27 profit and operates globally, with strong R&D and growth.

The Economic Times

Stocks in news: Reliance Industries, Wipro, Tata Motors, among 9 stocks that will be in focus today

The BSE Sensex ended at 76,944.28, lower by 12.99 points or 0.02%, as gains in IT, FMCG and select heavyweights helped limit the fall.

The Economic Times

Ahead of Market: 10 things that will decide stock market action on Wednesday

Indian equities declined as rising crude prices and a weaker rupee weighed on sentiment. Sensex fell 388 points and Nifty 112 points, while analysts flagged 24,400 as key support amid geopolitical risks and upcoming inflation data.

The Economic Times

Read news from The Economist, FT, and more,
with one subscription

Gland Pharma shares rally 12% after Q1FY27 profit jumps 47% YoY. Should you buy, sell or hold?

Gland Pharma shares rose sharply after Q1FY27 profit rose 47% and revenue grew 20% year-on-year. While strong margins and CDMO growth prompted Elara Securities to raise its earnings estimates, the brokerage downgraded the stock to ‘Accumulate’ from ‘Buy’ after its 40% three-month rally, citing limited near-term upside.

The Economic Times

Gland Pharma inks strategic CDMO deal with global pharma firm, eyes $90-100 million annual revenue

Gland Pharma has signed a strategic Manufacturing and Supply Agreement with a leading global pharmaceutical company for technology transfer, manufacturing and supply of sterile injectable products. The agreement covers 55 SKUs across three sites, with annualised revenue potential of $90-100 million upon commercialisation. Revenue generation is expected to begin in…

The Economic Times

Dividend alert: Jio Financial, Power Grid, HPCL among 90 stocks turning ex-dividend this week

Nearly 90 companies, including Jio Financial Services, Power Grid Corporation, HPCL, and Hindustan Aeronautics, will turn ex-dividend between August 10 and August 14. Investors holding these shares in their demat accounts on the respective record dates will be eligible to receive the announced corporate dividend payouts.

The Economic Times

Reliance Industries, Groww and MTAR Technologies among stocks bought and sold by mutual funds in June

Mutual funds invested Rs 50,600 crore in stocks during June. They significantly bought JSWInfra, Bajaj Finance, and HDFC Bank. Conversely, Asian Paints, ICICI Bank, and SBI saw major reductions. In midcaps, JSW Infrastructure and Meesho were key additions by funds. Smallcap segment saw buying in Acme Solar Holdings and Craftsman…

The Economic Times

Ahead of Market: 10 things that will decide stock market action on Wednesday

Indian equities declined for a second session as investors stayed cautious despite easing geopolitical tensions. Sensex lost nearly 250 points and Nifty fell over 80, while analysts expect recovery if the index holds above the crucial 23,800 support level.

The Economic Times

F&O Talk: Weak market breadth to keep Nifty in sideways trend. Sudeep Shah's take on Amber, Tata Comm and 4 more stocks

Indian markets ended higher on Friday, led by financial stocks, but analysts said Nifty remains trapped in a narrow range amid weak momentum and limited sector participation. Technical indicators suggest consolidation may continue until a decisive breakout emerges, while banking and IT sectors remain closely watched.

The Economic Times

Gland Pharma shares jump 11% as Q4 profit soars 97% YoY, co announces Rs 20/share final dividend

Shares of Gland Pharma rallied on Monday after the company reported a 97% YoY surge in Q4 profit and strong revenue growth, driven by its CDMO business. The board also announced a ₹20-per-share final dividend for FY26, boosting investor sentiment.

The Economic Times

Get all your
news in one place.

100's of premium titles.
One news app.

People

Sudeep Shah

38 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.